Press Release : ARTIDIS investigates nanomechanical tissue signature to improve response to radio/immuno-therapy in lung cancer marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
TAITRA organised event to protect health of overseas Chinese and Taiwanese businessmen 18:00 | 17/12/2020
The Overseas Taiwanese Healthcare
Webinar was jointly organized by TAITRA and the Overseas Community Affairs Council, under the guidance of the Ministry of Health and Welfare. Photo: TAITRA
During the event, doctors introduced the Eucare App and New Southbound Health Center and shared the latest proton therapy technologies from Taiwan, as well as teaching how to read health check reports and air pollution issues. This event attracted 1,013 online visits to participate and interact.
Leonor F. M. Lin, president and CEO of TAITRA, stated in her opening speech that to share Taiwanâs epidemic prevention information with the world, TAITRA has incorporated resources such as the epidemic prevention supply chain and epidemic prevention expertise to establish the Taiwan Global Anti-COVID-19 Pavilion website.
Errant DNA triggers immune system response against cancer
DNA that ends up where it doesn t belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate. The findings, published online today in
Cancer Cell, suggest that delivering radiation - which triggers DNA release from cells - before immunotherapy could be an effective way to fight cancers that are challenging to treat.
Nearly a decade ago, the Food and Drug Administration approved checkpoint inhibitors, a type of immunotherapy that removes defenses that allow cancer cells to masquerade as healthy cells, prompting the immune system to attack them. In 2015, researchers showed that these therapies had particular promise for cancers prompted by defects in cells mismatch repair system, which proofreads DNA as it is copied. If this system is faulty, genetic mutations quickly build, spurring some cells to become malignant.
Faculty of Radiation Oncology 2018 workforce census: the status of the radiation oncology workforce in New Zealand
Open Access
PDF Download
Health workforce planning requires a complex interplay of factors: changing workforce demographics, the education required for the appropriate skill set (a time lag for training means the workforce cannot rapidly adapt to increases in the number of skilled personnel required), recruitment and retention, organisational culture and the demand (again, a complex interplay of incidence, changes in population demographics and other treatment options). Radiation oncology is integral to cancer care, with one in two cancer patients estimated to benefit from radiation treatment.3 Thus, workforce planning is vital to ensure this crucial service is able to meet future needs. This article presents the results of the sixth Royal Australian and New Zealand College of Radiologists (RANZCR) radiation oncologist and trainee workforce census, surveying the Aust
Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes
Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime. When diagnosed, a patient s disease is graded from 1 to 5 based on how aggressive it is, with 5 being the most aggressive. Those with grades 4/5 disease are at the highest risk of poor outcomes or death from the disease; however, there are no immunologic or genomic indicators that can help physicians determine the best course of treatment for this group of patients.